Finally, 50 μM of piceatannol, a lesser studied analogue of resveratrol, has been proven to have antiadipogenic properties by limiting lipid synthesis and accumulation in hMSC-derived adipocytes, lowering glucose transport into adipocytes and inhibiting the PPARγ pathway, and thereby can be used in the treatment of metabolic complications associated with obesity [40]. This evidence concerns the gene PPARG and obesity disorder.